AVBP · ArriVent BioPharma, Inc.
Market Cap
$1.53B
Shares
49.31M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 22 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts
CIK
1868279
CUSIP
04272N102
13F (30d)
133 filings
133 filers
Visit website
Investor relations